Monday, December 19, 2016

UPDATE 1-Clovis's ovarian cancer drug wins accelerated FDA approval

Dec 19 (Reuters) - The U.S. Food and Drug Administration

said on Monday it granted accelerated approval to Clovis

Oncology Inc's ovarian cancer drug in patients whose

disease advanced despite chemotherapy.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)